BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25845371)

  • 1. Familial Ehlers-Danlos syndrome with lethal arterial events caused by a mutation in COL5A1.
    Monroe GR; Harakalova M; van der Crabben SN; Majoor-Krakauer D; Bertoli-Avella AM; Moll FL; Oranen BI; Dooijes D; Vink A; Knoers NV; Maugeri A; Pals G; Nijman IJ; van Haaften G; Baas AF
    Am J Med Genet A; 2015 Jun; 167(6):1196-203. PubMed ID: 25845371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial rupture in classic Ehlers-Danlos syndrome with COL5A1 mutation.
    Borck G; Beighton P; Wilhelm C; Kohlhase J; Kubisch C
    Am J Med Genet A; 2010 Aug; 152A(8):2090-3. PubMed ID: 20635400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound phenotype of osteogenesis imperfecta and Ehlers-Danlos syndrome caused by combined mutations in
    Lin Z; Zeng J; Wang X
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31239369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients.
    Malfait F; Coucke P; Symoens S; Loeys B; Nuytinck L; De Paepe A
    Hum Mutat; 2005 Jan; 25(1):28-37. PubMed ID: 15580559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygosity and Heterozygosity for Null Col5a2 Alleles Produce Embryonic Lethality and a Novel Classic Ehlers-Danlos Syndrome-Related Phenotype.
    Park AC; Phillips CL; Pfeiffer FM; Roenneburg DA; Kernien JF; Adams SM; Davidson JM; Birk DE; Greenspan DS
    Am J Pathol; 2015 Jul; 185(7):2000-11. PubMed ID: 25987251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonosomal Mosaicism for a Novel
    Micale L; Foiadelli T; Russo F; Cinque L; Bassanese F; Granatiero M; Fusco C; Savasta S; Castori M
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineation of Ehlers-Danlos syndrome phenotype due to the c.934C>T, p.(Arg312Cys) mutation in COL1A1: Report on a three-generation family without cardiovascular events, and literature review.
    Colombi M; Dordoni C; Venturini M; Zanca A; Calzavara-Pinton P; Ritelli M
    Am J Med Genet A; 2017 Feb; 173(2):524-530. PubMed ID: 28102596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Two Independent
    Bauer A; Bateman JF; Lamandé SR; Hanssen E; Kirejczyk SGM; Yee M; Ramiche A; Jagannathan V; Welle M; Leeb T; Bateman FL
    Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31546637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the novel COL5A1 c.3369_3431dup, p.(Glu1124_Gly1144dup) variant in a patient with incomplete classical Ehlers-Danlos syndrome: The importance of phenotype-guided genetic testing.
    Ritelli M; Cinquina V; Venturini M; Colombi M
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1422. PubMed ID: 32720758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient with a novel pathogenic variant in COL5A1 exhibiting prominent vascular and cardiac features.
    Lavanya K; Mahtani K; Abbott J; Jain A; Selvam P; Atwal H; Farres H; Atwal PS
    Am J Med Genet A; 2022 Jul; 188(7):2192-2197. PubMed ID: 35396906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome.
    Giunta C; Nuytinck L; Raghunath M; Hausser I; De Paepe A; Steinmann B
    Am J Med Genet; 2002 May; 109(4):284-90. PubMed ID: 11992482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics in classic Ehlers-Danlos syndrome.
    Malfait F; De Paepe A
    Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):17-23. PubMed ID: 16278879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classic Ehlers-Dalnos syndrome presenting as atypical chronic haematoma: a case report with novel frameshift mutation in COL5A1.
    Chiu WC; Chen SH; Lo MC; Kuo YT
    BMC Pediatr; 2020 Oct; 20(1):495. PubMed ID: 33109150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular characterization of 40 patients with classic Ehlers-Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations.
    Ritelli M; Dordoni C; Venturini M; Chiarelli N; Quinzani S; Traversa M; Zoppi N; Vascellaro A; Wischmeijer A; Manfredini E; Garavelli L; Calzavara-Pinton P; Colombi M
    Orphanet J Rare Dis; 2013 Apr; 8():58. PubMed ID: 23587214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria.
    Symoens S; Syx D; Malfait F; Callewaert B; De Backer J; Vanakker O; Coucke P; De Paepe A
    Hum Mutat; 2012 Oct; 33(10):1485-93. PubMed ID: 22696272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel splice variant in the N-propeptide of COL5A1 causes an EDS phenotype with severe kyphoscoliosis and eye involvement.
    Symoens S; Malfait F; Vlummens P; Hermanns-Lê T; Syx D; De Paepe A
    PLoS One; 2011; 6(5):e20121. PubMed ID: 21611149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
    Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
    Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural abnormalities of the cornea and lid resulting from collagen V mutations.
    Segev F; Héon E; Cole WG; Wenstrup RJ; Young F; Slomovic AR; Rootman DS; Whitaker-Menezes D; Chervoneva I; Birk DE
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):565-73. PubMed ID: 16431952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model.
    D'hondt S; Guillemyn B; Syx D; Symoens S; De Rycke R; Vanhoutte L; Toussaint W; Lambrecht BN; De Paepe A; Keene DR; Ishikawa Y; Bächinger HP; Janssens S; Bertrand MJM; Malfait F
    Matrix Biol; 2018 Sep; 70():72-83. PubMed ID: 29551664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound heterozygosity for a disease-causing G1489E [corrected] and disease-modifying G530S substitution in COL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: an explanation of intrafamilial variability?
    Giunta C; Steinmann B
    Am J Med Genet; 2000 Jan; 90(1):72-9. PubMed ID: 10602121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.